The global gene synthesis industry is set for significant growth, with its valuation projected to rise from USD 779.4 million in 2023 to over USD 4.5 billion by 2033. This expansion reflects a remarkable CAGR of 19.2% during the forecast period.
Key Drivers of Market Growth:
- Rising Demand for Synthetic Biology Applications:
- The growing application of synthetic biology in drug discovery, genetic engineering, and agricultural innovation is fueling the demand for advanced gene synthesis technologies.
- Advancements in Genomic Research:
- Progress in genome sequencing and molecular biology is driving the adoption of synthetic genes to accelerate research and development in personalized medicine.
- Cost-Effective and Custom Solutions:
- Innovations in gene synthesis techniques have reduced production costs while enabling customized gene sequences, broadening their accessibility across various industries.
- Expanding Biopharma Sector:
- The biopharmaceutical industry’s increasing reliance on synthetic genes for vaccine development, antibody production, and cell therapy contributes significantly to market growth.
- Government and Institutional Support:
- Rising funding for genomic research and synthetic biology projects is further accelerating the development and adoption of gene synthesis technologies.
A Full Report Overview – https://www.futuremarketinsights.com/reports/gene-synthesis-market
Market Outlook:
The gene synthesis market is poised for exponential growth, driven by its pivotal role in advancing healthcare, agriculture, and industrial biotechnology. Industry players are expected to focus on innovations, collaborations, and scaling up manufacturing capabilities to meet surging demand.
Stay updated as the global gene synthesis market redefines possibilities in biotechnology and genomic science.
Gene Synthesis in Healthcare Sector: Growth Prospects
CRISPR-based therapeutics can be adapted in near-limitless ways using a new gene editing platform developed by Northwestern University researchers.
After the onset of the COVID-19 pandemic, significant companies have invested in vaccine development in response to the ongoing pandemic. As a result, gene synthesis markets using vaccine development-based gene synthesis are expected to show positive growth opportunities soon.
Chemotherapy and immunotherapy combined with targeted therapy will grow considerably in the coming years. This would create lucrative opportunities for both established and emerging companies in the healthcare sector. In addition, the focus on molecular-level research will boost demand for gene synthesis over the next few years as clinical research is intensified. In the near future, synthetic biology may enable the design of microorganisms that are capable of finding cancer cells. Microbes designed for this purpose could secrete toxic proteins that could kill cancer cells with minimal side effects and with precision.
Key Players assist Gene Therapy Companies leverage their Capabilities
The companies operating in the gene synthesis market are expanding their single-guide RNA manufacturing capabilities. This would certainly enable next-generation gene and cell therapy research and development programs to advance their clinical trials. In December 2022, cell and gene therapy companies leveraged GenScript’s cGMP and sgRNA capability to accelerate speed.
Key developments in the market are:
- In September 2022, GenScript and Avectas collaborated to improve the non-viral cell therapy manufacturing process.
- In January 2023, Twist Bioscience and Astellas entered into a multitarget antibody discovery research collaboration.
Gene Synthesis Market Segmentation
By Service:
- Gene Synthesis Service (Standard Gene Service, Express Gene Service, Complex Gene Service, Custom Gene Synthesis Service)
- Gene Fragments Service
- GMP Gene Synthesis
- Others
By Application:
- Diagnostics
- Therapeutics
- Research and Development Activities
- Others
By End User:
- Academic and Research Institutes
- Biotechnology Companies
- Pharmaceutical Companies
- Contract Research Organization
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- The Middle East and Africa
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube